Colgate-Palmolive (NYSE:CL) Stock Position Boosted by Clearstead Trust LLC

Clearstead Trust LLC lifted its stake in Colgate-Palmolive (NYSE:CL) by 10.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,614 shares of the company’s stock after acquiring an additional 240 shares during the period. Clearstead Trust LLC’s holdings in Colgate-Palmolive were worth $208,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in CL. Vest Financial LLC lifted its holdings in Colgate-Palmolive by 25.1% in the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock valued at $29,498,000 after acquiring an additional 74,337 shares during the last quarter. Central Bank & Trust Co. increased its holdings in shares of Colgate-Palmolive by 22.1% in the fourth quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock valued at $110,000 after buying an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC lifted its position in shares of Colgate-Palmolive by 9.2% during the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock valued at $864,000 after acquiring an additional 910 shares during the last quarter. Sarasin & Partners LLP boosted its stake in shares of Colgate-Palmolive by 1.2% during the 4th quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after acquiring an additional 49,980 shares in the last quarter. Finally, Cornerstone Wealth Management LLC raised its position in shares of Colgate-Palmolive by 2.5% during the fourth quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock worth $571,000 after purchasing an additional 172 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have issued reports on CL shares. Wells Fargo & Company boosted their price objective on Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a report on Monday, April 29th. Royal Bank of Canada increased their price objective on Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a research note on Monday, April 29th. Barclays increased their price target on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 30th. Morgan Stanley upped their price objective on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, January 29th. Finally, Citigroup increased their price target on Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, April 16th. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $91.44.

Colgate-Palmolive Price Performance

Shares of CL stock traded down $0.03 during trading hours on Friday, hitting $92.88. 5,432,695 shares of the company’s stock were exchanged, compared to its average volume of 4,878,342. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $93.25. The stock has a market cap of $76.20 billion, a price-to-earnings ratio of 29.39, a price-to-earnings-growth ratio of 3.43 and a beta of 0.40. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.28. The stock’s 50-day moving average is $88.35 and its 200-day moving average is $82.35.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. The firm had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The company’s revenue was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.73 EPS. As a group, research analysts forecast that Colgate-Palmolive will post 3.52 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a yield of 2.15%. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s payout ratio is currently 63.29%.

Insider Activity

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the transaction, the chief executive officer now owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jennifer Daniels sold 3,538 shares of Colgate-Palmolive stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total transaction of $299,562.46. Following the transaction, the insider now directly owns 59,698 shares in the company, valued at $5,054,629.66. The disclosure for this sale can be found here. In the last quarter, insiders have sold 159,048 shares of company stock valued at $13,336,846. 0.34% of the stock is currently owned by insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.